PTK2 and breast cancer: Mechanistic studies indicate that PTK2 deletion in mammary tumor cells reduces the expression/phosphorylation of ERK1/2 contributing to the tumor dormancy in vivo and arrests growth in cultures suggesting PTK2 signaling through ERK-MAPK pathway is required to maintain tumor cell growth.